微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 3.31% | 20.36% | 90.23% | 81/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 1.74% | 34.88% | 132% | 90/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 0.75% | 17.19% | -68.09% | 97/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 2.35% | 172.76% | -14.55% | 85/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 2.75% | 231.33% | 113.18% | 96/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 1.29% | 4200% | 101.56% | 98/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 0.64% | 256.1% | 119.81% | 107/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -3.23% | 55.93% | -489.16% | 118/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 0.83% | 127.85% | 2666.67% | 109/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 0.03% | -95.31% | 107.32% | 118/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | -0.41% | -5.13% | 94.41% | 118/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | -7.33% | -923.6% | -145.97% | 128/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | -2.98% | -322.39% | -565.63% | 124/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 0.64% | 33.33% | 264.1% | 114/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | -0.39% | 62.5% | -143.82% | 112/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 0.89% | -76.46% | -33.58% | 106/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 1.34% | -77.85% | 179.17% | 95/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 0.48% | -76.35% | 146.15% | 105/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | -1.04% | -226.83% | -127.51% | 96/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 3.78% | 709.68% | -37.52% | 99/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 6.05% | 1.17% | 198.03% | 59/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 2.03% | 27.67% | 147.56% | 88/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 0.82% | 64% | 232.26% | 88/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | -0.62% | -237.78% | -110.37% | 122/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 5.98% | 348.13% | 276.1% | 55/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 1.59% | 126.86% | 218% | 89/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 0.5% | 119.38% | 11.11% | 91/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 0.45% | 0% | 118.67% | 116/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | -2.41% | -449.28% | 59.29% | 98/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | -5.92% | -51.02% | -129.46% | 104/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | -2.58% | -27.09% | -673.33% | 89/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 0.45% | 106.11% | -34.78% | 104/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 0.69% | -97% | 117.6% | 76/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | -3.92% | 34.12% | -93.1% | 89/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | -2.03% | 34.52% | 72.46% | 80/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | -7.37% | 12.16% | -132.06% | 101/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 22.99% | 549.02% | 486.39% | 3/160 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | -5.95% | 29.83% | -91.94% | 81/160 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | -3.1% | 33.19% | 63.05% | 73/160 | 2.41% | 华东医药 | 26.63% | 行业排名> |